BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 50312278 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccccc1)C(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C29H36N4O5/c1-5-6-17-23(26(34)27(35)30-20(4)21-13-9-7-10-14-21)31-29(36)37-24(19(2)3)18-25-32-33-28(38-25)22-15-11-8-12-16-22/h7-16,19-20,23-24H,5-6,17-18H2,1-4H3,(H,30,35)(H,31,36) VVDNYBNRSBCUTQ-UHFFFAOYSA-N 50169481 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2-methyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-propyl ester::CHEMBL189604 Procathepsin L Homo sapiens 17000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169481&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 10164961 104054285 CHEMBL189604 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312279 CCCC[C@H](NC(=O)O[C@H](Cn1ccc(n1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 |r| InChI=1S/C27H33F3N6O4/c1-5-6-7-20(23(37)24(38)33-22-12-14-31-34-22)32-25(39)40-21(26(2,3)4)16-36-15-13-19(35-36)17-8-10-18(11-9-17)27(28,29)30/h8-15,20-21H,5-7,16H2,1-4H3,(H,32,39)(H2,31,33,34,38) NFPHFQIUODNJRD-UHFFFAOYSA-N 19783 (2S)-3,3-dimethyl-1-{3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-yl}butan-2-yl N-[(2S)-1-oxo-1-(1H-pyrazol-5-ylcarbamoyl)hexan-2-yl]carbamate::CHEMBL234367::ketoamide, 2 Procathepsin L Homo sapiens 8700.0 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19783 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19783&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 10231379 46519787 CHEMBL234367 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312280 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C26H31F3N6O5/c1-5-6-7-17(21(36)22(37)32-19-12-13-30-33-19)31-24(38)39-18(25(2,3)4)14-20-34-35-23(40-20)15-8-10-16(11-9-15)26(27,28)29/h8-13,17-18H,5-7,14H2,1-4H3,(H,31,38)(H2,30,32,33,37) LBKFBCRXNHVDOJ-UHFFFAOYSA-N 50169482 [(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-[5-(4-trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-propyl ester::(R)-3,3-dimethyl-1-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::CHEMBL188400 Cathepsin B Homo sapiens 45000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169482&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 10231447 104054286 CHEMBL188400 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312281 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C30H37FN4O5/c1-6-7-13-23(26(36)27(37)32-19(2)20-11-9-8-10-12-20)33-29(38)39-24(30(3,4)5)18-25-34-35-28(40-25)21-14-16-22(31)17-15-21/h8-12,14-17,19,23-24H,6-7,13,18H2,1-5H3,(H,32,37)(H,33,38) YTRZAWRAPFBEQT-UHFFFAOYSA-N 50169483 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::(R)-1-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)-3,3-dimethylbutan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::CHEMBL188438 Cathepsin B Homo sapiens 9800.0 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169483&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 10120133 104054287 CHEMBL188438 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312282 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C30H37FN4O5/c1-6-7-13-23(26(36)27(37)32-19(2)20-11-9-8-10-12-20)33-29(38)39-24(30(3,4)5)18-25-34-35-28(40-25)21-14-16-22(31)17-15-21/h8-12,14-17,19,23-24H,6-7,13,18H2,1-5H3,(H,32,37)(H,33,38) YTRZAWRAPFBEQT-UHFFFAOYSA-N 50169483 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::(R)-1-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)-3,3-dimethylbutan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::CHEMBL188438 Cathepsin S Homo sapiens 530 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169483&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10120133 104054287 CHEMBL188438 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312283 CCCC[C@H](NC(=O)O[C@H](Cn1ccc(n1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccccn1 InChI=1S/C29H34F3N5O4/c1-5-6-9-22(25(38)26(39)35-24-10-7-8-16-33-24)34-27(40)41-23(28(2,3)4)18-37-17-15-21(36-37)19-11-13-20(14-12-19)29(30,31)32/h7-8,10-17,22-23H,5-6,9,18H2,1-4H3,(H,34,40)(H,33,35,39) FTMVKLBMILBPTA-UHFFFAOYSA-N 50169485 [(S)-1-(Pyridin-2-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[3-(4-trifluoromethyl-phenyl)-pyrazol-1-ylmethyl]-propyl ester::CHEMBL188929 Cathepsin K Homo sapiens 8100 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169485&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 10303526 104054289 CHEMBL188929 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312284 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)NCc1cccnc1 InChI=1S/C28H34FN5O5/c1-5-6-9-21(24(35)25(36)31-17-18-8-7-14-30-16-18)32-27(37)38-22(28(2,3)4)15-23-33-34-26(39-23)19-10-12-20(29)13-11-19/h7-8,10-14,16,21-22H,5-6,9,15,17H2,1-4H3,(H,31,36)(H,32,37) MYHNQSMNCJFCQY-UHFFFAOYSA-N 50169484 (R)-1-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)-3,3-dimethylbutan-2-yl(S)-1,2-dioxo-1-(pyridin-3-ylmethylamino)heptan-3-ylcarbamate::[(S)-1-(Pyridin-3-ylmethyl)-aminooxalyl]-pentyl)-carbamic acid (R)-1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::CHEMBL189417 Cathepsin S Homo sapiens 2700 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169484&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 44397693 104054288 CHEMBL189417 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312285 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccccc1)C(C)(C)CC)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C31H40N4O5/c1-6-8-19-24(27(36)28(37)32-21(3)22-15-11-9-12-16-22)33-30(38)39-25(31(4,5)7-2)20-26-34-35-29(40-26)23-17-13-10-14-18-23/h9-18,21,24-25H,6-8,19-20H2,1-5H3,(H,32,37)(H,33,38) KRBLLEUQYHGADE-UHFFFAOYSA-N 50169486 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-butyl ester::CHEMBL188563 Cathepsin B Homo sapiens 56000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169486&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 10302710 104054290 CHEMBL188563 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312286 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)NN1CCOC1=O InChI=1S/C26H32F3N5O7/c1-5-6-7-17(20(35)21(36)33-34-12-13-39-24(34)38)30-23(37)40-18(25(2,3)4)14-19-31-32-22(41-19)15-8-10-16(11-9-15)26(27,28)29/h8-11,17-18H,5-7,12-14H2,1-4H3,(H,30,37)(H,33,36) IXXKXSFSQVTOKQ-UHFFFAOYSA-N 50169488 (1R)-2,2-DIMETHYL-1-({5-[4-(TRIFLUOROMETHYL)PHENYL]-1,3,4-OXADIAZOL-2-YL}METHYL)PROPYL (1S)-1-{OXO[(2-OXO-1,3-OXAZOLIDIN-3-YL)AMINO]ACETYL}PENTYLCARBAMATE::(R)-3,3-dimethyl-1-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-(2-oxooxazolidin-3-ylamino)heptan-3-ylcarbamate::[(S)-1-(2-Oxo-oxazolidin-3-ylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-[5-(4-trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-propyl ester::CHEMBL365822 Cathepsin K Homo sapiens 130 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169488&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 5287498 104054292 CHEMBL365822 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312287 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccccc1)C(C)(C)CC)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C31H40N4O5/c1-6-8-19-24(27(36)28(37)32-21(3)22-15-11-9-12-16-22)33-30(38)39-25(31(4,5)7-2)20-26-34-35-29(40-26)23-17-13-10-14-18-23/h9-18,21,24-25H,6-8,19-20H2,1-5H3,(H,32,37)(H,33,38) KRBLLEUQYHGADE-UHFFFAOYSA-N 50169486 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-butyl ester::CHEMBL188563 Cathepsin S Homo sapiens 720 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169486&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10302710 104054290 CHEMBL188563 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312288 CCCC[C@H](NC(=O)OC(Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)N[C@H]1CCCNC1=O InChI=1S/C27H36FN5O6/c1-5-6-8-18(22(34)24(36)30-19-9-7-14-29-23(19)35)31-26(37)38-20(27(2,3)4)15-21-32-33-25(39-21)16-10-12-17(28)13-11-16/h10-13,18-20H,5-9,14-15H2,1-4H3,(H,29,35)(H,30,36)(H,31,37) AQMZQDJVQGMOQG-UHFFFAOYSA-N 50169487 [(S)-1-((S)-2-Oxo-piperidin-3-ylaminooxalyl)-pentyl]-carbamic acid 1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::CHEMBL426617 Procathepsin L Homo sapiens 15000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169487&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 44397423 104054291 CHEMBL426617 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312289 CCCC[C@H](NC(=O)O[C@H](CN1CCN(C1=O)c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C27H35F3N6O5/c1-5-6-7-19(22(37)23(38)33-21-12-13-31-34-21)32-24(39)41-20(26(2,3)4)16-35-14-15-36(25(35)40)18-10-8-17(9-11-18)27(28,29)30/h8-13,19-20H,5-7,14-16H2,1-4H3,(H,32,39)(H2,31,33,34,38) ADKVCJPUSODNCK-UHFFFAOYSA-N 50169490 (S)-3,3-dimethyl-1-(2-oxo-3-(4-(trifluoromethyl)phenyl)imidazolidin-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::[(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[2-oxo-3-(4-trifluoromethyl-phenyl)-imidazolidin-1-ylmethyl]-propyl ester::CHEMBL191178 Cathepsin K Homo sapiens 340 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169490&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 44397609 104054294 CHEMBL191178 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312290 CCCC[C@H](NC(=O)O[C@H](Cn1ccc(n1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)NCc1ccno1 InChI=1S/C28H34F3N5O5/c1-5-6-7-22(24(37)25(38)32-16-20-12-14-33-41-20)34-26(39)40-23(27(2,3)4)17-36-15-13-21(35-36)18-8-10-19(11-9-18)28(29,30)31/h8-15,22-23H,5-7,16-17H2,1-4H3,(H,32,38)(H,34,39) XVOFWCZHBSJNKQ-UHFFFAOYSA-N 50169489 [(S)-1-(Isoxazol-5-ylmethyl)-aminooxalyl]-pentyl)-carbamic acid (S)-2,2-dimethyl-1-[3-(4-trifluoromethyl-phenyl)-pyrazol-1-ylmethyl]-propyl ester::CHEMBL365049 Procathepsin L Homo sapiens 1000000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169489&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 10120903 104054293 CHEMBL365049 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312291 CCCC[C@H](NC(=O)O[C@H](Cn1ccc(n1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)NCc1ccno1 InChI=1S/C28H34F3N5O5/c1-5-6-7-22(24(37)25(38)32-16-20-12-14-33-41-20)34-26(39)40-23(27(2,3)4)17-36-15-13-21(35-36)18-8-10-19(11-9-18)28(29,30)31/h8-15,22-23H,5-7,16-17H2,1-4H3,(H,32,38)(H,34,39) XVOFWCZHBSJNKQ-UHFFFAOYSA-N 50169489 [(S)-1-(Isoxazol-5-ylmethyl)-aminooxalyl]-pentyl)-carbamic acid (S)-2,2-dimethyl-1-[3-(4-trifluoromethyl-phenyl)-pyrazol-1-ylmethyl]-propyl ester::CHEMBL365049 Cathepsin K Homo sapiens 5800 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169489&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 10120903 104054293 CHEMBL365049 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312292 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)NN1CCOC1=O InChI=1S/C26H32F3N5O7/c1-5-6-7-17(20(35)21(36)33-34-12-13-39-24(34)38)30-23(37)40-18(25(2,3)4)14-19-31-32-22(41-19)15-8-10-16(11-9-15)26(27,28)29/h8-11,17-18H,5-7,12-14H2,1-4H3,(H,30,37)(H,33,36) IXXKXSFSQVTOKQ-UHFFFAOYSA-N 50169488 (1R)-2,2-DIMETHYL-1-({5-[4-(TRIFLUOROMETHYL)PHENYL]-1,3,4-OXADIAZOL-2-YL}METHYL)PROPYL (1S)-1-{OXO[(2-OXO-1,3-OXAZOLIDIN-3-YL)AMINO]ACETYL}PENTYLCARBAMATE::(R)-3,3-dimethyl-1-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-(2-oxooxazolidin-3-ylamino)heptan-3-ylcarbamate::[(S)-1-(2-Oxo-oxazolidin-3-ylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-[5-(4-trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-propyl ester::CHEMBL365822 Cathepsin B Homo sapiens 5200 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169488&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 5287498 104054292 CHEMBL365822 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312293 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)NCc1cccnc1 InChI=1S/C28H34FN5O5/c1-5-6-9-21(24(35)25(36)31-17-18-8-7-14-30-16-18)32-27(37)38-22(28(2,3)4)15-23-33-34-26(39-23)19-10-12-20(29)13-11-19/h7-8,10-14,16,21-22H,5-6,9,15,17H2,1-4H3,(H,31,36)(H,32,37) MYHNQSMNCJFCQY-UHFFFAOYSA-N 50169484 (R)-1-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)-3,3-dimethylbutan-2-yl(S)-1,2-dioxo-1-(pyridin-3-ylmethylamino)heptan-3-ylcarbamate::[(S)-1-(Pyridin-3-ylmethyl)-aminooxalyl]-pentyl)-carbamic acid (R)-1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::CHEMBL189417 Cathepsin B Homo sapiens 18000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169484&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 44397693 104054288 CHEMBL189417 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312294 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C25H31FN6O5/c1-5-6-7-17(21(33)22(34)29-19-12-13-27-30-19)28-24(35)36-18(25(2,3)4)14-20-31-32-23(37-20)15-8-10-16(26)11-9-15/h8-13,17-18H,5-7,14H2,1-4H3,(H,28,35)(H2,27,29,30,34) QCFNLTHDXRFFKG-UHFFFAOYSA-N 50169491 [(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (R)-1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::CHEMBL186149 Cathepsin K Homo sapiens 4900 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169491&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 10186046 104054295 CHEMBL186149 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312295 CCCC[C@H](NC(=O)O[C@H](CN1CCN(C1=O)c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C27H35F3N6O5/c1-5-6-7-19(22(37)23(38)33-21-12-13-31-34-21)32-24(39)41-20(26(2,3)4)16-35-14-15-36(25(35)40)18-10-8-17(9-11-18)27(28,29)30/h8-13,19-20H,5-7,14-16H2,1-4H3,(H,32,39)(H2,31,33,34,38) ADKVCJPUSODNCK-UHFFFAOYSA-N 50169490 (S)-3,3-dimethyl-1-(2-oxo-3-(4-(trifluoromethyl)phenyl)imidazolidin-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::[(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[2-oxo-3-(4-trifluoromethyl-phenyl)-imidazolidin-1-ylmethyl]-propyl ester::CHEMBL191178 Cathepsin L2 Homo sapiens 1700 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169490&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 44397609 104054294 CHEMBL191178 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312296 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C30H37FN4O5/c1-6-7-13-23(26(36)27(37)32-19(2)20-11-9-8-10-12-20)33-29(38)39-24(30(3,4)5)18-25-34-35-28(40-25)21-14-16-22(31)17-15-21/h8-12,14-17,19,23-24H,6-7,13,18H2,1-5H3,(H,32,37)(H,33,38) YTRZAWRAPFBEQT-UHFFFAOYSA-N 50169483 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::(R)-1-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)-3,3-dimethylbutan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::CHEMBL188438 Procathepsin L Homo sapiens 33000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169483&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 10120133 104054287 CHEMBL188438 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312297 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C31H37F3N4O5/c1-6-7-13-23(26(39)27(40)35-19(2)20-11-9-8-10-12-20)36-29(41)42-24(30(3,4)5)18-25-37-38-28(43-25)21-14-16-22(17-15-21)31(32,33)34/h8-12,14-17,19,23-24H,6-7,13,18H2,1-5H3,(H,35,40)(H,36,41) VZYZUCSJVPOQDE-UHFFFAOYSA-N 50169492 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-[5-(4-trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-propyl ester::(R)-3,3-dimethyl-1-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::CHEMBL363773 Cathepsin K Homo sapiens 410 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169492&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 10210867 104054296 CHEMBL363773 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312298 CCCC[C@H](NC(=O)O[C@H](Cn1cnc(c1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C27H33F3N6O4/c1-5-6-7-19(23(37)24(38)34-22-12-13-32-35-22)33-25(39)40-21(26(2,3)4)15-36-14-20(31-16-36)17-8-10-18(11-9-17)27(28,29)30/h8-14,16,19,21H,5-7,15H2,1-4H3,(H,33,39)(H2,32,34,35,38) IBVYZTXPOAZNHM-UHFFFAOYSA-N 50169493 (S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::[(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[4-(4-trifluoromethyl-phenyl)-imidazol-1-ylmethyl]-propyl ester::CHEMBL191584 Cathepsin K Homo sapiens 26 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169493&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 10187920 104054297 CHEMBL191584 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312299 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C30H37FN4O5/c1-6-7-13-23(26(36)27(37)32-19(2)20-11-9-8-10-12-20)33-29(38)39-24(30(3,4)5)18-25-34-35-28(40-25)21-14-16-22(31)17-15-21/h8-12,14-17,19,23-24H,6-7,13,18H2,1-5H3,(H,32,37)(H,33,38) YTRZAWRAPFBEQT-UHFFFAOYSA-N 50169483 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::(R)-1-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)-3,3-dimethylbutan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::CHEMBL188438 Cathepsin K Homo sapiens 370 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169483&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 10120133 104054287 CHEMBL188438 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312300 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccccc1)C(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C29H36N4O5/c1-5-6-17-23(26(34)27(35)30-20(4)21-13-9-7-10-14-21)31-29(36)37-24(19(2)3)18-25-32-33-28(38-25)22-15-11-8-12-16-22/h7-16,19-20,23-24H,5-6,17-18H2,1-4H3,(H,30,35)(H,31,36) VVDNYBNRSBCUTQ-UHFFFAOYSA-N 50169481 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2-methyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-propyl ester::CHEMBL189604 Cathepsin K Homo sapiens 830.0 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169481&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 10164961 104054285 CHEMBL189604 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312301 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C26H31F3N6O5/c1-5-6-7-17(21(36)22(37)32-19-12-13-30-33-19)31-24(38)39-18(25(2,3)4)14-20-34-35-23(40-20)15-8-10-16(11-9-15)26(27,28)29/h8-13,17-18H,5-7,14H2,1-4H3,(H,31,38)(H2,30,32,33,37) LBKFBCRXNHVDOJ-UHFFFAOYSA-N 50169482 [(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-[5-(4-trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-propyl ester::(R)-3,3-dimethyl-1-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::CHEMBL188400 Cathepsin S Homo sapiens 520 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169482&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10231447 104054286 CHEMBL188400 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312302 CCCC[C@H](NC(=O)O[C@H](Cn1ccc(n1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccccn1 InChI=1S/C29H34F3N5O4/c1-5-6-9-22(25(38)26(39)35-24-10-7-8-16-33-24)34-27(40)41-23(28(2,3)4)18-37-17-15-21(36-37)19-11-13-20(14-12-19)29(30,31)32/h7-8,10-17,22-23H,5-6,9,18H2,1-4H3,(H,34,40)(H,33,35,39) FTMVKLBMILBPTA-UHFFFAOYSA-N 50169485 [(S)-1-(Pyridin-2-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[3-(4-trifluoromethyl-phenyl)-pyrazol-1-ylmethyl]-propyl ester::CHEMBL188929 Cathepsin S Homo sapiens 3700 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169485&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10303526 104054289 CHEMBL188929 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312303 CCCC[C@H](NC(=O)O[C@@H](Cc1nnc(o1)-c1ccccc1)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C30H38N4O5/c1-6-7-18-23(26(35)27(36)31-20(2)21-14-10-8-11-15-21)32-29(37)38-24(30(3,4)5)19-25-33-34-28(39-25)22-16-12-9-13-17-22/h8-17,20,23-24H,6-7,18-19H2,1-5H3,(H,31,36)(H,32,37) OOESIBLDEWSAMK-UHFFFAOYSA-N 50169494 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-propyl ester::(S)-3,3-dimethyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::CHEMBL191588 Cathepsin K Homo sapiens 460000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169494&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 10230391 104054298 CHEMBL191588 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312304 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C31H37F3N4O5/c1-6-7-13-23(26(39)27(40)35-19(2)20-11-9-8-10-12-20)36-29(41)42-24(30(3,4)5)18-25-37-38-28(43-25)21-14-16-22(17-15-21)31(32,33)34/h8-12,14-17,19,23-24H,6-7,13,18H2,1-5H3,(H,35,40)(H,36,41) VZYZUCSJVPOQDE-UHFFFAOYSA-N 50169492 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-[5-(4-trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-propyl ester::(R)-3,3-dimethyl-1-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::CHEMBL363773 Cathepsin B Homo sapiens 32000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169492&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 10210867 104054296 CHEMBL363773 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312305 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C31H37F3N4O5/c1-6-7-13-23(26(39)27(40)35-19(2)20-11-9-8-10-12-20)36-29(41)42-24(30(3,4)5)18-25-37-38-28(43-25)21-14-16-22(17-15-21)31(32,33)34/h8-12,14-17,19,23-24H,6-7,13,18H2,1-5H3,(H,35,40)(H,36,41) VZYZUCSJVPOQDE-UHFFFAOYSA-N 50169492 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-[5-(4-trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-propyl ester::(R)-3,3-dimethyl-1-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::CHEMBL363773 Cathepsin L2 Homo sapiens 5000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169492&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 10210867 104054296 CHEMBL363773 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312306 CCCC[C@H](NC(=O)O[C@H](CN1CCN(C1=O)c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C27H35F3N6O5/c1-5-6-7-19(22(37)23(38)33-21-12-13-31-34-21)32-24(39)41-20(26(2,3)4)16-35-14-15-36(25(35)40)18-10-8-17(9-11-18)27(28,29)30/h8-13,19-20H,5-7,14-16H2,1-4H3,(H,32,39)(H2,31,33,34,38) ADKVCJPUSODNCK-UHFFFAOYSA-N 50169490 (S)-3,3-dimethyl-1-(2-oxo-3-(4-(trifluoromethyl)phenyl)imidazolidin-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::[(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[2-oxo-3-(4-trifluoromethyl-phenyl)-imidazolidin-1-ylmethyl]-propyl ester::CHEMBL191178 Procathepsin L Homo sapiens 37000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169490&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 44397609 104054294 CHEMBL191178 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312307 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C30H37FN4O5/c1-6-7-13-23(26(36)27(37)32-19(2)20-11-9-8-10-12-20)33-29(38)39-24(30(3,4)5)18-25-34-35-28(40-25)21-14-16-22(31)17-15-21/h8-12,14-17,19,23-24H,6-7,13,18H2,1-5H3,(H,32,37)(H,33,38) YTRZAWRAPFBEQT-UHFFFAOYSA-N 50169483 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::(R)-1-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)-3,3-dimethylbutan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::CHEMBL188438 Cathepsin L2 Homo sapiens 34000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169483&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 10120133 104054287 CHEMBL188438 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312308 CCCC[C@H](NC(=O)O[C@H](Cn1cc(cn1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C27H33F3N6O4/c1-5-6-7-20(23(37)24(38)34-22-12-13-31-35-22)33-25(39)40-21(26(2,3)4)16-36-15-18(14-32-36)17-8-10-19(11-9-17)27(28,29)30/h8-15,20-21H,5-7,16H2,1-4H3,(H,33,39)(H2,31,34,35,38) KXZLSPLTNDGSNP-UHFFFAOYSA-N 50169495 [(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[4-(4-trifluoromethyl-phenyl)-pyrazol-1-ylmethyl]-propyl ester::(S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-pyrazol-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::CHEMBL190053 Cathepsin B Homo sapiens 10000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169495&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 10166544 104054299 CHEMBL190053 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312309 CCCC[C@H](NC(=O)O[C@H](Cn1cc(cn1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C27H33F3N6O4/c1-5-6-7-20(23(37)24(38)34-22-12-13-31-35-22)33-25(39)40-21(26(2,3)4)16-36-15-18(14-32-36)17-8-10-19(11-9-17)27(28,29)30/h8-15,20-21H,5-7,16H2,1-4H3,(H,33,39)(H2,31,34,35,38) KXZLSPLTNDGSNP-UHFFFAOYSA-N 50169495 [(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[4-(4-trifluoromethyl-phenyl)-pyrazol-1-ylmethyl]-propyl ester::(S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-pyrazol-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::CHEMBL190053 Cathepsin S Homo sapiens 78 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169495&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10166544 104054299 CHEMBL190053 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312310 CCCC[C@H](NC(=O)OC(Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)N[C@H]1CCCNC1=O InChI=1S/C27H36FN5O6/c1-5-6-8-18(22(34)24(36)30-19-9-7-14-29-23(19)35)31-26(37)38-20(27(2,3)4)15-21-32-33-25(39-21)16-10-12-17(28)13-11-16/h10-13,18-20H,5-9,14-15H2,1-4H3,(H,29,35)(H,30,36)(H,31,37) AQMZQDJVQGMOQG-UHFFFAOYSA-N 50169487 [(S)-1-((S)-2-Oxo-piperidin-3-ylaminooxalyl)-pentyl]-carbamic acid 1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::CHEMBL426617 Cathepsin K Homo sapiens 650 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169487&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 44397423 104054291 CHEMBL426617 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312311 CCCC[C@H](NC(=O)O[C@H](Cn1ccc(n1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)NCc1ccno1 InChI=1S/C28H34F3N5O5/c1-5-6-7-22(24(37)25(38)32-16-20-12-14-33-41-20)34-26(39)40-23(27(2,3)4)17-36-15-13-21(35-36)18-8-10-19(11-9-18)28(29,30)31/h8-15,22-23H,5-7,16-17H2,1-4H3,(H,32,38)(H,34,39) XVOFWCZHBSJNKQ-UHFFFAOYSA-N 50169489 [(S)-1-(Isoxazol-5-ylmethyl)-aminooxalyl]-pentyl)-carbamic acid (S)-2,2-dimethyl-1-[3-(4-trifluoromethyl-phenyl)-pyrazol-1-ylmethyl]-propyl ester::CHEMBL365049 Cathepsin L2 Homo sapiens 36000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169489&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 10120903 104054293 CHEMBL365049 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312312 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)NN1CCOC1=O InChI=1S/C26H32F3N5O7/c1-5-6-7-17(20(35)21(36)33-34-12-13-39-24(34)38)30-23(37)40-18(25(2,3)4)14-19-31-32-22(41-19)15-8-10-16(11-9-15)26(27,28)29/h8-11,17-18H,5-7,12-14H2,1-4H3,(H,30,37)(H,33,36) IXXKXSFSQVTOKQ-UHFFFAOYSA-N 50169488 (1R)-2,2-DIMETHYL-1-({5-[4-(TRIFLUOROMETHYL)PHENYL]-1,3,4-OXADIAZOL-2-YL}METHYL)PROPYL (1S)-1-{OXO[(2-OXO-1,3-OXAZOLIDIN-3-YL)AMINO]ACETYL}PENTYLCARBAMATE::(R)-3,3-dimethyl-1-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-(2-oxooxazolidin-3-ylamino)heptan-3-ylcarbamate::[(S)-1-(2-Oxo-oxazolidin-3-ylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-[5-(4-trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-propyl ester::CHEMBL365822 Cathepsin L2 Homo sapiens 7100 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169488&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 5287498 104054292 CHEMBL365822 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312313 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C25H31FN6O5/c1-5-6-7-17(21(33)22(34)29-19-12-13-27-30-19)28-24(35)36-18(25(2,3)4)14-20-31-32-23(37-20)15-8-10-16(26)11-9-15/h8-13,17-18H,5-7,14H2,1-4H3,(H,28,35)(H2,27,29,30,34) QCFNLTHDXRFFKG-UHFFFAOYSA-N 50169491 [(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (R)-1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::CHEMBL186149 Cathepsin S Homo sapiens 110000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169491&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10186046 104054295 CHEMBL186149 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312314 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)NCc1cccnc1 InChI=1S/C28H34FN5O5/c1-5-6-9-21(24(35)25(36)31-17-18-8-7-14-30-16-18)32-27(37)38-22(28(2,3)4)15-23-33-34-26(39-23)19-10-12-20(29)13-11-19/h7-8,10-14,16,21-22H,5-6,9,15,17H2,1-4H3,(H,31,36)(H,32,37) MYHNQSMNCJFCQY-UHFFFAOYSA-N 50169484 (R)-1-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)-3,3-dimethylbutan-2-yl(S)-1,2-dioxo-1-(pyridin-3-ylmethylamino)heptan-3-ylcarbamate::[(S)-1-(Pyridin-3-ylmethyl)-aminooxalyl]-pentyl)-carbamic acid (R)-1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::CHEMBL189417 Cathepsin K Homo sapiens 2800 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169484&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 44397693 104054288 CHEMBL189417 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312315 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccccc1)C(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C29H36N4O5/c1-5-6-17-23(26(34)27(35)30-20(4)21-13-9-7-10-14-21)31-29(36)37-24(19(2)3)18-25-32-33-28(38-25)22-15-11-8-12-16-22/h7-16,19-20,23-24H,5-6,17-18H2,1-4H3,(H,30,35)(H,31,36) VVDNYBNRSBCUTQ-UHFFFAOYSA-N 50169481 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2-methyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-propyl ester::CHEMBL189604 Cathepsin S Homo sapiens 3700 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169481&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10164961 104054285 CHEMBL189604 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312316 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccccc1)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C30H38N4O5/c1-6-7-18-23(26(35)27(36)31-20(2)21-14-10-8-11-15-21)32-29(37)38-24(30(3,4)5)19-25-33-34-28(39-25)22-16-12-9-13-17-22/h8-17,20,23-24H,6-7,18-19H2,1-5H3,(H,31,36)(H,32,37) OOESIBLDEWSAMK-UHFFFAOYSA-N 50169496 (R)-3,3-dimethyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::[(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-propyl ester::CHEMBL186778 Cathepsin S Homo sapiens 750 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169496&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10165557 104054300 CHEMBL186778 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312317 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccccc1)C(C)(C)CC)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C31H40N4O5/c1-6-8-19-24(27(36)28(37)32-21(3)22-15-11-9-12-16-22)33-30(38)39-25(31(4,5)7-2)20-26-34-35-29(40-26)23-17-13-10-14-18-23/h9-18,21,24-25H,6-8,19-20H2,1-5H3,(H,32,37)(H,33,38) KRBLLEUQYHGADE-UHFFFAOYSA-N 50169486 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-butyl ester::CHEMBL188563 Procathepsin L Homo sapiens 17000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169486&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 10302710 104054290 CHEMBL188563 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312318 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccccc1)C(C)(C)CC)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C31H40N4O5/c1-6-8-19-24(27(36)28(37)32-21(3)22-15-11-9-12-16-22)33-30(38)39-25(31(4,5)7-2)20-26-34-35-29(40-26)23-17-13-10-14-18-23/h9-18,21,24-25H,6-8,19-20H2,1-5H3,(H,32,37)(H,33,38) KRBLLEUQYHGADE-UHFFFAOYSA-N 50169486 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-butyl ester::CHEMBL188563 Cathepsin L2 Homo sapiens 2800 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169486&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 10302710 104054290 CHEMBL188563 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312319 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C26H31F3N6O5/c1-5-6-7-17(21(36)22(37)32-19-12-13-30-33-19)31-24(38)39-18(25(2,3)4)14-20-34-35-23(40-20)15-8-10-16(11-9-15)26(27,28)29/h8-13,17-18H,5-7,14H2,1-4H3,(H,31,38)(H2,30,32,33,37) LBKFBCRXNHVDOJ-UHFFFAOYSA-N 50169482 [(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-[5-(4-trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-propyl ester::(R)-3,3-dimethyl-1-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::CHEMBL188400 Cathepsin L2 Homo sapiens 1200 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169482&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 10231447 104054286 CHEMBL188400 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312320 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)NN1CCOC1=O InChI=1S/C26H32F3N5O7/c1-5-6-7-17(20(35)21(36)33-34-12-13-39-24(34)38)30-23(37)40-18(25(2,3)4)14-19-31-32-22(41-19)15-8-10-16(11-9-15)26(27,28)29/h8-11,17-18H,5-7,12-14H2,1-4H3,(H,30,37)(H,33,36) IXXKXSFSQVTOKQ-UHFFFAOYSA-N 50169488 (1R)-2,2-DIMETHYL-1-({5-[4-(TRIFLUOROMETHYL)PHENYL]-1,3,4-OXADIAZOL-2-YL}METHYL)PROPYL (1S)-1-{OXO[(2-OXO-1,3-OXAZOLIDIN-3-YL)AMINO]ACETYL}PENTYLCARBAMATE::(R)-3,3-dimethyl-1-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-(2-oxooxazolidin-3-ylamino)heptan-3-ylcarbamate::[(S)-1-(2-Oxo-oxazolidin-3-ylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-[5-(4-trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-propyl ester::CHEMBL365822 Procathepsin L Homo sapiens 160000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169488&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 5287498 104054292 CHEMBL365822 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312321 CCCC[C@H](NC(=O)O[C@H](Cn1cnc(c1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1nccs1 InChI=1S/C27H32F3N5O4S/c1-5-6-7-19(22(36)23(37)34-24-31-12-13-40-24)33-25(38)39-21(26(2,3)4)15-35-14-20(32-16-35)17-8-10-18(11-9-17)27(28,29)30/h8-14,16,19,21H,5-7,15H2,1-4H3,(H,33,38)(H,31,34,37) MCTBHWIGQYRUBZ-UHFFFAOYSA-N 50169497 [(S)-1-(Thiazol-2-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[4-(4-trifluoromethyl-phenyl)-imidazol-1-ylmethyl]-propyl ester::(S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)butan-2-yl(S)-1,2-dioxo-1-(thiazol-2-ylamino)heptan-3-ylcarbamate::CHEMBL187864 Procathepsin L Homo sapiens 1000000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169497&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 10303657 104054301 CHEMBL187864 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312322 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)NN1CCOC1=O InChI=1S/C26H32F3N5O7/c1-5-6-7-17(20(35)21(36)33-34-12-13-39-24(34)38)30-23(37)40-18(25(2,3)4)14-19-31-32-22(41-19)15-8-10-16(11-9-15)26(27,28)29/h8-11,17-18H,5-7,12-14H2,1-4H3,(H,30,37)(H,33,36) IXXKXSFSQVTOKQ-UHFFFAOYSA-N 50169488 (1R)-2,2-DIMETHYL-1-({5-[4-(TRIFLUOROMETHYL)PHENYL]-1,3,4-OXADIAZOL-2-YL}METHYL)PROPYL (1S)-1-{OXO[(2-OXO-1,3-OXAZOLIDIN-3-YL)AMINO]ACETYL}PENTYLCARBAMATE::(R)-3,3-dimethyl-1-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-(2-oxooxazolidin-3-ylamino)heptan-3-ylcarbamate::[(S)-1-(2-Oxo-oxazolidin-3-ylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-[5-(4-trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-propyl ester::CHEMBL365822 Cathepsin S Homo sapiens 1200 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169488&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 5287498 104054292 CHEMBL365822 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312323 CCCC[C@H](NC(=O)O[C@H](Cn1ccc(n1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 |r| InChI=1S/C27H33F3N6O4/c1-5-6-7-20(23(37)24(38)33-22-12-14-31-34-22)32-25(39)40-21(26(2,3)4)16-36-15-13-19(35-36)17-8-10-18(11-9-17)27(28,29)30/h8-15,20-21H,5-7,16H2,1-4H3,(H,32,39)(H2,31,33,34,38) NFPHFQIUODNJRD-UHFFFAOYSA-N 19783 (2S)-3,3-dimethyl-1-{3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-yl}butan-2-yl N-[(2S)-1-oxo-1-(1H-pyrazol-5-ylcarbamoyl)hexan-2-yl]carbamate::CHEMBL234367::ketoamide, 2 Cathepsin L2 Homo sapiens 170 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19783 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19783&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 10231379 46519787 CHEMBL234367 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312324 CCCC[C@H](NC(=O)O[C@H](Cn1ccc(n1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 |r| InChI=1S/C27H33F3N6O4/c1-5-6-7-20(23(37)24(38)33-22-12-14-31-34-22)32-25(39)40-21(26(2,3)4)16-36-15-13-19(35-36)17-8-10-18(11-9-17)27(28,29)30/h8-15,20-21H,5-7,16H2,1-4H3,(H,32,39)(H2,31,33,34,38) NFPHFQIUODNJRD-UHFFFAOYSA-N 19783 (2S)-3,3-dimethyl-1-{3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-yl}butan-2-yl N-[(2S)-1-oxo-1-(1H-pyrazol-5-ylcarbamoyl)hexan-2-yl]carbamate::CHEMBL234367::ketoamide, 2 Cathepsin S Homo sapiens 210 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19783 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19783&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10231379 46519787 CHEMBL234367 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312325 CCCC[C@H](NC(=O)O[C@H](Cn1cnc(c1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C27H33F3N6O4/c1-5-6-7-19(23(37)24(38)34-22-12-13-32-35-22)33-25(39)40-21(26(2,3)4)15-36-14-20(31-16-36)17-8-10-18(11-9-17)27(28,29)30/h8-14,16,19,21H,5-7,15H2,1-4H3,(H,33,39)(H2,32,34,35,38) IBVYZTXPOAZNHM-UHFFFAOYSA-N 50169493 (S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::[(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[4-(4-trifluoromethyl-phenyl)-imidazol-1-ylmethyl]-propyl ester::CHEMBL191584 Procathepsin L Homo sapiens 10000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169493&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 10187920 104054297 CHEMBL191584 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312326 CCCC[C@H](NC(=O)O[C@H](Cn1cnc(c1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1nccs1 InChI=1S/C27H32F3N5O4S/c1-5-6-7-19(22(36)23(37)34-24-31-12-13-40-24)33-25(38)39-21(26(2,3)4)15-35-14-20(32-16-35)17-8-10-18(11-9-17)27(28,29)30/h8-14,16,19,21H,5-7,15H2,1-4H3,(H,33,38)(H,31,34,37) MCTBHWIGQYRUBZ-UHFFFAOYSA-N 50169497 [(S)-1-(Thiazol-2-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[4-(4-trifluoromethyl-phenyl)-imidazol-1-ylmethyl]-propyl ester::(S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)butan-2-yl(S)-1,2-dioxo-1-(thiazol-2-ylamino)heptan-3-ylcarbamate::CHEMBL187864 Cathepsin L2 Homo sapiens 36000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169497&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 10303657 104054301 CHEMBL187864 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312327 CCCC[C@H](NC(=O)O[C@H](Cn1cc(cn1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C27H33F3N6O4/c1-5-6-7-20(23(37)24(38)34-22-12-13-31-35-22)33-25(39)40-21(26(2,3)4)16-36-15-18(14-32-36)17-8-10-19(11-9-17)27(28,29)30/h8-15,20-21H,5-7,16H2,1-4H3,(H,33,39)(H2,31,34,35,38) KXZLSPLTNDGSNP-UHFFFAOYSA-N 50169495 [(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[4-(4-trifluoromethyl-phenyl)-pyrazol-1-ylmethyl]-propyl ester::(S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-pyrazol-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::CHEMBL190053 Cathepsin K Homo sapiens 32 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169495&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 10166544 104054299 CHEMBL190053 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312328 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccccc1)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C30H38N4O5/c1-6-7-18-23(26(35)27(36)31-20(2)21-14-10-8-11-15-21)32-29(37)38-24(30(3,4)5)19-25-33-34-28(39-25)22-16-12-9-13-17-22/h8-17,20,23-24H,6-7,18-19H2,1-5H3,(H,31,36)(H,32,37) OOESIBLDEWSAMK-UHFFFAOYSA-N 50169496 (R)-3,3-dimethyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::[(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-propyl ester::CHEMBL186778 Cathepsin K Homo sapiens 240 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169496&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 10165557 104054300 CHEMBL186778 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312329 CCCC[C@H](NC(=O)OC(Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)N[C@H]1CCCNC1=O InChI=1S/C27H36FN5O6/c1-5-6-8-18(22(34)24(36)30-19-9-7-14-29-23(19)35)31-26(37)38-20(27(2,3)4)15-21-32-33-25(39-21)16-10-12-17(28)13-11-16/h10-13,18-20H,5-9,14-15H2,1-4H3,(H,29,35)(H,30,36)(H,31,37) AQMZQDJVQGMOQG-UHFFFAOYSA-N 50169487 [(S)-1-((S)-2-Oxo-piperidin-3-ylaminooxalyl)-pentyl]-carbamic acid 1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::CHEMBL426617 Cathepsin S Homo sapiens 810.0 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169487&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 44397423 104054291 CHEMBL426617 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312330 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccccc1)C(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C29H36N4O5/c1-5-6-17-23(26(34)27(35)30-20(4)21-13-9-7-10-14-21)31-29(36)37-24(19(2)3)18-25-32-33-28(38-25)22-15-11-8-12-16-22/h7-16,19-20,23-24H,5-6,17-18H2,1-4H3,(H,30,35)(H,31,36) VVDNYBNRSBCUTQ-UHFFFAOYSA-N 50169481 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2-methyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-propyl ester::CHEMBL189604 Cathepsin L2 Homo sapiens 5600 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169481&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 10164961 104054285 CHEMBL189604 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312331 CCCC[C@H](NC(=O)O[C@H](Cn1cc(cn1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C27H33F3N6O4/c1-5-6-7-20(23(37)24(38)34-22-12-13-31-35-22)33-25(39)40-21(26(2,3)4)16-36-15-18(14-32-36)17-8-10-19(11-9-17)27(28,29)30/h8-15,20-21H,5-7,16H2,1-4H3,(H,33,39)(H2,31,34,35,38) KXZLSPLTNDGSNP-UHFFFAOYSA-N 50169495 [(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[4-(4-trifluoromethyl-phenyl)-pyrazol-1-ylmethyl]-propyl ester::(S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-pyrazol-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::CHEMBL190053 Procathepsin L Homo sapiens 36000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169495&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 10166544 104054299 CHEMBL190053 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312332 CCCC[C@H](NC(=O)O[C@H](CN1CCN(C1=O)c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C27H35F3N6O5/c1-5-6-7-19(22(37)23(38)33-21-12-13-31-34-21)32-24(39)41-20(26(2,3)4)16-35-14-15-36(25(35)40)18-10-8-17(9-11-18)27(28,29)30/h8-13,19-20H,5-7,14-16H2,1-4H3,(H,32,39)(H2,31,33,34,38) ADKVCJPUSODNCK-UHFFFAOYSA-N 50169490 (S)-3,3-dimethyl-1-(2-oxo-3-(4-(trifluoromethyl)phenyl)imidazolidin-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::[(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[2-oxo-3-(4-trifluoromethyl-phenyl)-imidazolidin-1-ylmethyl]-propyl ester::CHEMBL191178 Cathepsin S Homo sapiens 540 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169490&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 44397609 104054294 CHEMBL191178 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312333 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)NCc1cccnc1 InChI=1S/C28H34FN5O5/c1-5-6-9-21(24(35)25(36)31-17-18-8-7-14-30-16-18)32-27(37)38-22(28(2,3)4)15-23-33-34-26(39-23)19-10-12-20(29)13-11-19/h7-8,10-14,16,21-22H,5-6,9,15,17H2,1-4H3,(H,31,36)(H,32,37) MYHNQSMNCJFCQY-UHFFFAOYSA-N 50169484 (R)-1-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)-3,3-dimethylbutan-2-yl(S)-1,2-dioxo-1-(pyridin-3-ylmethylamino)heptan-3-ylcarbamate::[(S)-1-(Pyridin-3-ylmethyl)-aminooxalyl]-pentyl)-carbamic acid (R)-1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::CHEMBL189417 Procathepsin L Homo sapiens 130000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169484&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 44397693 104054288 CHEMBL189417 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312334 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C25H31FN6O5/c1-5-6-7-17(21(33)22(34)29-19-12-13-27-30-19)28-24(35)36-18(25(2,3)4)14-20-31-32-23(37-20)15-8-10-16(26)11-9-15/h8-13,17-18H,5-7,14H2,1-4H3,(H,28,35)(H2,27,29,30,34) QCFNLTHDXRFFKG-UHFFFAOYSA-N 50169491 [(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (R)-1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::CHEMBL186149 Cathepsin L2 Homo sapiens 230000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169491&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 10186046 104054295 CHEMBL186149 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312335 CCCC[C@H](NC(=O)O[C@H](Cn1cnc(c1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1nccs1 InChI=1S/C27H32F3N5O4S/c1-5-6-7-19(22(36)23(37)34-24-31-12-13-40-24)33-25(38)39-21(26(2,3)4)15-35-14-20(32-16-35)17-8-10-18(11-9-17)27(28,29)30/h8-14,16,19,21H,5-7,15H2,1-4H3,(H,33,38)(H,31,34,37) MCTBHWIGQYRUBZ-UHFFFAOYSA-N 50169497 [(S)-1-(Thiazol-2-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[4-(4-trifluoromethyl-phenyl)-imidazol-1-ylmethyl]-propyl ester::(S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)butan-2-yl(S)-1,2-dioxo-1-(thiazol-2-ylamino)heptan-3-ylcarbamate::CHEMBL187864 Cathepsin S Homo sapiens 19000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169497&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10303657 104054301 CHEMBL187864 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312336 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C25H31FN6O5/c1-5-6-7-17(21(33)22(34)29-19-12-13-27-30-19)28-24(35)36-18(25(2,3)4)14-20-31-32-23(37-20)15-8-10-16(26)11-9-15/h8-13,17-18H,5-7,14H2,1-4H3,(H,28,35)(H2,27,29,30,34) QCFNLTHDXRFFKG-UHFFFAOYSA-N 50169491 [(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (R)-1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::CHEMBL186149 Procathepsin L Homo sapiens 3800000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169491&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 10186046 104054295 CHEMBL186149 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312337 CCCC[C@H](NC(=O)O[C@H](Cn1cnc(c1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1nccs1 InChI=1S/C27H32F3N5O4S/c1-5-6-7-19(22(36)23(37)34-24-31-12-13-40-24)33-25(38)39-21(26(2,3)4)15-35-14-20(32-16-35)17-8-10-18(11-9-17)27(28,29)30/h8-14,16,19,21H,5-7,15H2,1-4H3,(H,33,38)(H,31,34,37) MCTBHWIGQYRUBZ-UHFFFAOYSA-N 50169497 [(S)-1-(Thiazol-2-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[4-(4-trifluoromethyl-phenyl)-imidazol-1-ylmethyl]-propyl ester::(S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)butan-2-yl(S)-1,2-dioxo-1-(thiazol-2-ylamino)heptan-3-ylcarbamate::CHEMBL187864 Cathepsin K Homo sapiens 5800 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169497&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 10303657 104054301 CHEMBL187864 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312338 CCCC[C@H](NC(=O)O[C@H](Cn1ccc(n1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 |r| InChI=1S/C27H33F3N6O4/c1-5-6-7-20(23(37)24(38)33-22-12-14-31-34-22)32-25(39)40-21(26(2,3)4)16-36-15-13-19(35-36)17-8-10-18(11-9-17)27(28,29)30/h8-15,20-21H,5-7,16H2,1-4H3,(H,32,39)(H2,31,33,34,38) NFPHFQIUODNJRD-UHFFFAOYSA-N 19783 (2S)-3,3-dimethyl-1-{3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-yl}butan-2-yl N-[(2S)-1-oxo-1-(1H-pyrazol-5-ylcarbamoyl)hexan-2-yl]carbamate::CHEMBL234367::ketoamide, 2 Cathepsin K Homo sapiens 72.0 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19783 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19783&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 10231379 46519787 CHEMBL234367 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312339 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccccc1)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C30H38N4O5/c1-6-7-18-23(26(35)27(36)31-20(2)21-14-10-8-11-15-21)32-29(37)38-24(30(3,4)5)19-25-33-34-28(39-25)22-16-12-9-13-17-22/h8-17,20,23-24H,6-7,18-19H2,1-5H3,(H,31,36)(H,32,37) OOESIBLDEWSAMK-UHFFFAOYSA-N 50169496 (R)-3,3-dimethyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::[(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-propyl ester::CHEMBL186778 Procathepsin L Homo sapiens 10000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169496&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 10165557 104054300 CHEMBL186778 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312340 CCCC[C@H](NC(=O)O[C@H](Cn1cnc(c1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C27H33F3N6O4/c1-5-6-7-19(23(37)24(38)34-22-12-13-32-35-22)33-25(39)40-21(26(2,3)4)15-36-14-20(31-16-36)17-8-10-18(11-9-17)27(28,29)30/h8-14,16,19,21H,5-7,15H2,1-4H3,(H,33,39)(H2,32,34,35,38) IBVYZTXPOAZNHM-UHFFFAOYSA-N 50169493 (S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::[(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[4-(4-trifluoromethyl-phenyl)-imidazol-1-ylmethyl]-propyl ester::CHEMBL191584 Cathepsin S Homo sapiens 160 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169493&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10187920 104054297 CHEMBL191584 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312341 CCCC[C@H](NC(=O)O[C@H](CN1CCN(C1=O)c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C27H35F3N6O5/c1-5-6-7-19(22(37)23(38)33-21-12-13-31-34-21)32-24(39)41-20(26(2,3)4)16-35-14-15-36(25(35)40)18-10-8-17(9-11-18)27(28,29)30/h8-13,19-20H,5-7,14-16H2,1-4H3,(H,32,39)(H2,31,33,34,38) ADKVCJPUSODNCK-UHFFFAOYSA-N 50169490 (S)-3,3-dimethyl-1-(2-oxo-3-(4-(trifluoromethyl)phenyl)imidazolidin-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::[(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[2-oxo-3-(4-trifluoromethyl-phenyl)-imidazolidin-1-ylmethyl]-propyl ester::CHEMBL191178 Cathepsin B Homo sapiens 60000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169490&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 44397609 104054294 CHEMBL191178 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312342 CCCC[C@H](NC(=O)O[C@H](Cn1ccc(n1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccccn1 InChI=1S/C29H34F3N5O4/c1-5-6-9-22(25(38)26(39)35-24-10-7-8-16-33-24)34-27(40)41-23(28(2,3)4)18-37-17-15-21(36-37)19-11-13-20(14-12-19)29(30,31)32/h7-8,10-17,22-23H,5-6,9,18H2,1-4H3,(H,34,40)(H,33,35,39) FTMVKLBMILBPTA-UHFFFAOYSA-N 50169485 [(S)-1-(Pyridin-2-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[3-(4-trifluoromethyl-phenyl)-pyrazol-1-ylmethyl]-propyl ester::CHEMBL188929 Procathepsin L Homo sapiens 240000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169485&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 10303526 104054289 CHEMBL188929 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312343 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C25H31FN6O5/c1-5-6-7-17(21(33)22(34)29-19-12-13-27-30-19)28-24(35)36-18(25(2,3)4)14-20-31-32-23(37-20)15-8-10-16(26)11-9-15/h8-13,17-18H,5-7,14H2,1-4H3,(H,28,35)(H2,27,29,30,34) QCFNLTHDXRFFKG-UHFFFAOYSA-N 50169491 [(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (R)-1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::CHEMBL186149 Cathepsin B Homo sapiens 3500000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169491&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 10186046 104054295 CHEMBL186149 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312344 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C31H37F3N4O5/c1-6-7-13-23(26(39)27(40)35-19(2)20-11-9-8-10-12-20)36-29(41)42-24(30(3,4)5)18-25-37-38-28(43-25)21-14-16-22(17-15-21)31(32,33)34/h8-12,14-17,19,23-24H,6-7,13,18H2,1-5H3,(H,35,40)(H,36,41) VZYZUCSJVPOQDE-UHFFFAOYSA-N 50169492 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-[5-(4-trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-propyl ester::(R)-3,3-dimethyl-1-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::CHEMBL363773 Cathepsin S Homo sapiens 1600 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169492&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10210867 104054296 CHEMBL363773 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 50312345 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C26H31F3N6O5/c1-5-6-7-17(21(36)22(37)32-19-12-13-30-33-19)31-24(38)39-18(25(2,3)4)14-20-34-35-23(40-20)15-8-10-16(11-9-15)26(27,28)29/h8-13,17-18H,5-7,14H2,1-4H3,(H,31,38)(H2,30,32,33,37) LBKFBCRXNHVDOJ-UHFFFAOYSA-N 50169482 [(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-[5-(4-trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-propyl ester::(R)-3,3-dimethyl-1-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::CHEMBL188400 Cathepsin K Homo sapiens 29 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169482&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 10231447 104054286 CHEMBL188400 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312346 CCCC[C@H](NC(=O)O[C@H](Cn1cc(cn1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C27H33F3N6O4/c1-5-6-7-20(23(37)24(38)34-22-12-13-31-35-22)33-25(39)40-21(26(2,3)4)16-36-15-18(14-32-36)17-8-10-19(11-9-17)27(28,29)30/h8-15,20-21H,5-7,16H2,1-4H3,(H,33,39)(H2,31,34,35,38) KXZLSPLTNDGSNP-UHFFFAOYSA-N 50169495 [(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[4-(4-trifluoromethyl-phenyl)-pyrazol-1-ylmethyl]-propyl ester::(S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-pyrazol-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::CHEMBL190053 Cathepsin L2 Homo sapiens 430.0 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169495&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 10166544 104054299 CHEMBL190053 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312347 CCCC[C@H](NC(=O)O[C@H](Cn1cnc(c1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C27H33F3N6O4/c1-5-6-7-19(23(37)24(38)34-22-12-13-32-35-22)33-25(39)40-21(26(2,3)4)15-36-14-20(31-16-36)17-8-10-18(11-9-17)27(28,29)30/h8-14,16,19,21H,5-7,15H2,1-4H3,(H,33,39)(H2,32,34,35,38) IBVYZTXPOAZNHM-UHFFFAOYSA-N 50169493 (S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::[(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[4-(4-trifluoromethyl-phenyl)-imidazol-1-ylmethyl]-propyl ester::CHEMBL191584 Cathepsin L2 Homo sapiens 130 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169493&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 10187920 104054297 CHEMBL191584 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312348 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccccc1)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C30H38N4O5/c1-6-7-18-23(26(35)27(36)31-20(2)21-14-10-8-11-15-21)32-29(37)38-24(30(3,4)5)19-25-33-34-28(39-25)22-16-12-9-13-17-22/h8-17,20,23-24H,6-7,18-19H2,1-5H3,(H,31,36)(H,32,37) OOESIBLDEWSAMK-UHFFFAOYSA-N 50169496 (R)-3,3-dimethyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::[(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-propyl ester::CHEMBL186778 Cathepsin B Homo sapiens 12000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169496&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 10165557 104054300 CHEMBL186778 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312349 CCCC[C@H](NC(=O)O[C@H](Cn1ccc(n1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccccn1 InChI=1S/C29H34F3N5O4/c1-5-6-9-22(25(38)26(39)35-24-10-7-8-16-33-24)34-27(40)41-23(28(2,3)4)18-37-17-15-21(36-37)19-11-13-20(14-12-19)29(30,31)32/h7-8,10-17,22-23H,5-6,9,18H2,1-4H3,(H,34,40)(H,33,35,39) FTMVKLBMILBPTA-UHFFFAOYSA-N 50169485 [(S)-1-(Pyridin-2-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[3-(4-trifluoromethyl-phenyl)-pyrazol-1-ylmethyl]-propyl ester::CHEMBL188929 Cathepsin L2 Homo sapiens 4500 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169485&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 10303526 104054289 CHEMBL188929 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312350 CCCC[C@H](NC(=O)OC(Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)N[C@H]1CCCNC1=O InChI=1S/C27H36FN5O6/c1-5-6-8-18(22(34)24(36)30-19-9-7-14-29-23(19)35)31-26(37)38-20(27(2,3)4)15-21-32-33-25(39-21)16-10-12-17(28)13-11-16/h10-13,18-20H,5-9,14-15H2,1-4H3,(H,29,35)(H,30,36)(H,31,37) AQMZQDJVQGMOQG-UHFFFAOYSA-N 50169487 [(S)-1-((S)-2-Oxo-piperidin-3-ylaminooxalyl)-pentyl]-carbamic acid 1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::CHEMBL426617 Cathepsin B Homo sapiens 6200 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169487&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 44397423 104054291 CHEMBL426617 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312351 CCCC[C@H](NC(=O)O[C@H](Cn1cnc(c1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1nccs1 InChI=1S/C27H32F3N5O4S/c1-5-6-7-19(22(36)23(37)34-24-31-12-13-40-24)33-25(38)39-21(26(2,3)4)15-35-14-20(32-16-35)17-8-10-18(11-9-17)27(28,29)30/h8-14,16,19,21H,5-7,15H2,1-4H3,(H,33,38)(H,31,34,37) MCTBHWIGQYRUBZ-UHFFFAOYSA-N 50169497 [(S)-1-(Thiazol-2-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[4-(4-trifluoromethyl-phenyl)-imidazol-1-ylmethyl]-propyl ester::(S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)butan-2-yl(S)-1,2-dioxo-1-(thiazol-2-ylamino)heptan-3-ylcarbamate::CHEMBL187864 Cathepsin B Homo sapiens 870000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169497&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 10303657 104054301 CHEMBL187864 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312352 CCCC[C@H](NC(=O)O[C@H](Cn1ccc(n1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 |r| InChI=1S/C27H33F3N6O4/c1-5-6-7-20(23(37)24(38)33-22-12-14-31-34-22)32-25(39)40-21(26(2,3)4)16-36-15-13-19(35-36)17-8-10-18(11-9-17)27(28,29)30/h8-15,20-21H,5-7,16H2,1-4H3,(H,32,39)(H2,31,33,34,38) NFPHFQIUODNJRD-UHFFFAOYSA-N 19783 (2S)-3,3-dimethyl-1-{3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-yl}butan-2-yl N-[(2S)-1-oxo-1-(1H-pyrazol-5-ylcarbamoyl)hexan-2-yl]carbamate::CHEMBL234367::ketoamide, 2 Cathepsin B Homo sapiens 20000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19783 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19783&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 10231379 46519787 CHEMBL234367 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312353 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C26H31F3N6O5/c1-5-6-7-17(21(36)22(37)32-19-12-13-30-33-19)31-24(38)39-18(25(2,3)4)14-20-34-35-23(40-20)15-8-10-16(11-9-15)26(27,28)29/h8-13,17-18H,5-7,14H2,1-4H3,(H,31,38)(H2,30,32,33,37) LBKFBCRXNHVDOJ-UHFFFAOYSA-N 50169482 [(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-[5-(4-trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-propyl ester::(R)-3,3-dimethyl-1-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::CHEMBL188400 Procathepsin L Homo sapiens 69000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169482&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 10231447 104054286 CHEMBL188400 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312354 CCCC[C@H](NC(=O)OC(Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)N[C@H]1CCCNC1=O InChI=1S/C27H36FN5O6/c1-5-6-8-18(22(34)24(36)30-19-9-7-14-29-23(19)35)31-26(37)38-20(27(2,3)4)15-21-32-33-25(39-21)16-10-12-17(28)13-11-16/h10-13,18-20H,5-9,14-15H2,1-4H3,(H,29,35)(H,30,36)(H,31,37) AQMZQDJVQGMOQG-UHFFFAOYSA-N 50169487 [(S)-1-((S)-2-Oxo-piperidin-3-ylaminooxalyl)-pentyl]-carbamic acid 1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::CHEMBL426617 Cathepsin L2 Homo sapiens 1300 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169487&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 44397423 104054291 CHEMBL426617 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312355 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(F)cc1)C(C)(C)C)C(=O)C(=O)NCc1cccnc1 InChI=1S/C28H34FN5O5/c1-5-6-9-21(24(35)25(36)31-17-18-8-7-14-30-16-18)32-27(37)38-22(28(2,3)4)15-23-33-34-26(39-23)19-10-12-20(29)13-11-19/h7-8,10-14,16,21-22H,5-6,9,15,17H2,1-4H3,(H,31,36)(H,32,37) MYHNQSMNCJFCQY-UHFFFAOYSA-N 50169484 (R)-1-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)-3,3-dimethylbutan-2-yl(S)-1,2-dioxo-1-(pyridin-3-ylmethylamino)heptan-3-ylcarbamate::[(S)-1-(Pyridin-3-ylmethyl)-aminooxalyl]-pentyl)-carbamic acid (R)-1-[5-(4-fluoro-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-2,2-dimethyl-propyl ester::CHEMBL189417 Cathepsin L2 Homo sapiens 14000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169484&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 44397693 104054288 CHEMBL189417 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312356 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccccc1)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C30H38N4O5/c1-6-7-18-23(26(35)27(36)31-20(2)21-14-10-8-11-15-21)32-29(37)38-24(30(3,4)5)19-25-33-34-28(39-25)22-16-12-9-13-17-22/h8-17,20,23-24H,6-7,18-19H2,1-5H3,(H,31,36)(H,32,37) OOESIBLDEWSAMK-UHFFFAOYSA-N 50169496 (R)-3,3-dimethyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::[(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-propyl ester::CHEMBL186778 Cathepsin L2 Homo sapiens 1600 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2027&target=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169496&enzyme=Cathepsin+L2&column=ki&startPg=0&Increment=50&submit=Search 10165557 104054300 CHEMBL186778 1 MNLSLVLAAFCLGIASAVPKFDQNLDTKWYQWKATHRRLYGANEEGWRRAVWEKNMKMIELHNGEYSQGKHGFTMAMNAFGDMTNEEFRQMMGCFRNQKFRKGKVFREPLFLDLPKSVDWRKKGYVTPVKNQKQCGSCWAFSATGALEGQMFRKTGKLVSLSEQNLVDCSRPQGNQGCNGGFMARAFQYVKENGGLDSEESYPYVAVDEICKYRPENSVANDTGFTVVAPGKEKALMKAVATVGPISVAMDAGHSSFQFYKSGIYFEPDCSSKNLDHGVLVVGYGFEGANSNNSKYWLVKNSWGPEWGSNGYVKIAKDKNNHCGIATAASYPNV Cathepsin L2 CATL2_HUMAN O60911 O60233 Q2TB86 Q5T1U0 50312357 CCCC[C@H](NC(=O)O[C@H](Cn1ccc(n1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)NCc1ccno1 InChI=1S/C28H34F3N5O5/c1-5-6-7-22(24(37)25(38)32-16-20-12-14-33-41-20)34-26(39)40-23(27(2,3)4)17-36-15-13-21(35-36)18-8-10-19(11-9-18)28(29,30)31/h8-15,22-23H,5-7,16-17H2,1-4H3,(H,32,38)(H,34,39) XVOFWCZHBSJNKQ-UHFFFAOYSA-N 50169489 [(S)-1-(Isoxazol-5-ylmethyl)-aminooxalyl]-pentyl)-carbamic acid (S)-2,2-dimethyl-1-[3-(4-trifluoromethyl-phenyl)-pyrazol-1-ylmethyl]-propyl ester::CHEMBL365049 Cathepsin B Homo sapiens 870000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169489&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 10120903 104054293 CHEMBL365049 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312358 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccccc1)C(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C29H36N4O5/c1-5-6-17-23(26(34)27(35)30-20(4)21-13-9-7-10-14-21)31-29(36)37-24(19(2)3)18-25-32-33-28(38-25)22-15-11-8-12-16-22/h7-16,19-20,23-24H,5-6,17-18H2,1-4H3,(H,30,35)(H,31,36) VVDNYBNRSBCUTQ-UHFFFAOYSA-N 50169481 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2-methyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-propyl ester::CHEMBL189604 Cathepsin B Homo sapiens 31000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169481&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 10164961 104054285 CHEMBL189604 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312359 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccccc1)C(C)(C)CC)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C31H40N4O5/c1-6-8-19-24(27(36)28(37)32-21(3)22-15-11-9-12-16-22)33-30(38)39-25(31(4,5)7-2)20-26-34-35-29(40-26)23-17-13-10-14-18-23/h9-18,21,24-25H,6-8,19-20H2,1-5H3,(H,32,37)(H,33,38) KRBLLEUQYHGADE-UHFFFAOYSA-N 50169486 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-butyl ester::CHEMBL188563 Cathepsin K Homo sapiens 1500 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2049&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169486&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 10302710 104054290 CHEMBL188563 1 MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM 7PCK,1BY8,5JH3,5JA7,5J94,7QBN,6QL8,2R6N,1U9X,1U9W,1U9V,7QBO,7QBM,7NXM,7NXL,6QM0,6QLX,6QLW,6QLM,9G6A,8C3D,7QBL,6QBS,6HGY,5TUN,4YVA,4YV8,4X6J,4X6I,4X6H,4N8W,4N79,4DMY,4DMX,3O1G,3O0U,3KX1,3KWZ,3KWB,3KW9,3C9E,2FTD,2BDL,2AUZ,2AUX,2ATO,1YT7,1YK8,1YK7,1TU6,1Q6K,1NLJ,1NL6,1MEM,1BGO,1AYW,1AYV,1AYU,1AU4,1AU3,1AU2,1AU0,1ATK,1SNK,3OVZ Cathepsin K CATK_HUMAN P43235 Q6FHS6 50312360 CCCC[C@H](NC(=O)O[C@H](Cn1cnc(c1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccn[nH]1 InChI=1S/C27H33F3N6O4/c1-5-6-7-19(23(37)24(38)34-22-12-13-32-35-22)33-25(39)40-21(26(2,3)4)15-36-14-20(31-16-36)17-8-10-18(11-9-17)27(28,29)30/h8-14,16,19,21H,5-7,15H2,1-4H3,(H,33,39)(H2,32,34,35,38) IBVYZTXPOAZNHM-UHFFFAOYSA-N 50169493 (S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate::[(S)-1-(2H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[4-(4-trifluoromethyl-phenyl)-imidazol-1-ylmethyl]-propyl ester::CHEMBL191584 Cathepsin B Homo sapiens 27000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169493&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 10187920 104054297 CHEMBL191584 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312361 CCCC[C@H](NC(=O)O[C@H](Cn1ccc(n1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc1ccccn1 InChI=1S/C29H34F3N5O4/c1-5-6-9-22(25(38)26(39)35-24-10-7-8-16-33-24)34-27(40)41-23(28(2,3)4)18-37-17-15-21(36-37)19-11-13-20(14-12-19)29(30,31)32/h7-8,10-17,22-23H,5-6,9,18H2,1-4H3,(H,34,40)(H,33,35,39) FTMVKLBMILBPTA-UHFFFAOYSA-N 50169485 [(S)-1-(Pyridin-2-ylaminooxalyl)-pentyl]-carbamic acid (S)-2,2-dimethyl-1-[3-(4-trifluoromethyl-phenyl)-pyrazol-1-ylmethyl]-propyl ester::CHEMBL188929 Cathepsin B Homo sapiens 107000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169485&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 10303526 104054289 CHEMBL188929 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 50312362 CCCC[C@H](NC(=O)O[C@H](Cc1nnc(o1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)N[C@H](C)c1ccccc1 InChI=1S/C31H37F3N4O5/c1-6-7-13-23(26(39)27(40)35-19(2)20-11-9-8-10-12-20)36-29(41)42-24(30(3,4)5)18-25-37-38-28(43-25)21-14-16-22(17-15-21)31(32,33)34/h8-12,14-17,19,23-24H,6-7,13,18H2,1-5H3,(H,35,40)(H,36,41) VZYZUCSJVPOQDE-UHFFFAOYSA-N 50169492 [(S)-1-(1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (R)-2,2-dimethyl-1-[5-(4-trifluoromethyl-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-propyl ester::(R)-3,3-dimethyl-1-(5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)butan-2-yl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate::CHEMBL363773 Procathepsin L Homo sapiens 190000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169492&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 10210867 104054296 CHEMBL363773 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 50312363 CCCC[C@H](NC(=O)O[C@H](Cn1ccc(n1)-c1ccc(cc1)C(F)(F)F)C(C)(C)C)C(=O)C(=O)NCc1ccno1 InChI=1S/C28H34F3N5O5/c1-5-6-7-22(24(37)25(38)32-16-20-12-14-33-41-20)34-26(39)40-23(27(2,3)4)17-36-15-13-21(35-36)18-8-10-19(11-9-18)28(29,30)31/h8-15,22-23H,5-7,16-17H2,1-4H3,(H,32,38)(H,34,39) XVOFWCZHBSJNKQ-UHFFFAOYSA-N 50169489 [(S)-1-(Isoxazol-5-ylmethyl)-aminooxalyl]-pentyl)-carbamic acid (S)-2,2-dimethyl-1-[3-(4-trifluoromethyl-phenyl)-pyrazol-1-ylmethyl]-propyl ester::CHEMBL365049 Cathepsin S Homo sapiens 19000 ChEMBL 10.1016/j.bmcl.2005.05.062 10.7270/Q2FQ9W59 15982880 Barrett, DG; Boncek, VM; Catalano, JG; Deaton, DN; Hassell, AM; Jurgensen, CH; Long, ST; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Ray, JA; Samano, V; Shewchuk, LM; Tavares, FX; Wells-Knecht, KJ; Willard, DH; Wright, LL; Zhou, HQ 7/8/2005 11/10/2009 Glaxosmithkline http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50169489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50169489&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 10120903 104054293 CHEMBL365049 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3